← Back to Clinical Trials
Recruiting NCT06815601

NCT06815601 Neuromodulation After Spinal Cord Injury to Improve Limb Function

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06815601
Status Recruiting
Phase
Sponsor State University of New York at Buffalo
Condition Spinal Cord Injury
Study Type INTERVENTIONAL
Enrollment 60 participants
Start Date 2025-04-10
Primary Completion 2027-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
rTMSSham rTMSMotor training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 60 participants in total. It began in 2025-04-10 with a primary completion date of 2027-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The University at Buffalo (UB) Department of Rehabilitation Sciences is looking for adult volunteers with and without spinal cord injuries for a study on hand movement. The goal of the study is to learn about how the brain, nerves, and muscles of the body are connected and perform everyday tasks. This may help us to develop ways to improve the hand functions of people with spinal cord injuries.

Eligibility Criteria

Inclusion Criteria: * Healthy adults between the ages of 18-75 years old who are right-handed * Adults between the ages of 18-75 years old who have had a spinal cord injury (SCI) Exclusion Criteria: For both healthy individuals and those with SCI: * Uncontrolled medical problems including pulmonary, cardiovascular or orthopedic disease * Any debilitating disease prior to the SCI that caused exercise intolerance * Ongoing major depression or altered cognitive status * Metal plate in skull * History of seizures * Receiving drugs acting primarily on the central nervous system, which lower the seizure threshold such as antipsychotic drugs * Pregnant females

Contact & Investigator

Central Contact

Hang Jin Jo, PhD

✉ hangjinj@buffalo.edu

📞 716-829-2905

Principal Investigator

Hang Jin Jo, PhD

PRINCIPAL INVESTIGATOR

State University of New York at Buffalo

Frequently Asked Questions

Who can join the NCT06815601 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Spinal Cord Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06815601 currently recruiting?

Yes, NCT06815601 is actively recruiting participants. Contact the research team at hangjinj@buffalo.edu for enrollment information.

Where is the NCT06815601 trial being conducted?

This trial is being conducted at Buffalo, United States.

Who is sponsoring the NCT06815601 clinical trial?

NCT06815601 is sponsored by State University of New York at Buffalo. The principal investigator is Hang Jin Jo, PhD at State University of New York at Buffalo. The trial plans to enroll 60 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology